Volta, Francesco
 Distribuzione geografica
Continente #
EU - Europa 248
NA - Nord America 168
AS - Asia 78
AF - Africa 8
Totale 502
Nazione #
US - Stati Uniti d'America 167
IT - Italia 164
SG - Singapore 42
IE - Irlanda 30
CN - Cina 18
SE - Svezia 15
NL - Olanda 13
CI - Costa d'Avorio 8
JP - Giappone 5
DE - Germania 4
FR - Francia 4
GB - Regno Unito 4
AT - Austria 3
BE - Belgio 3
FI - Finlandia 3
IN - India 3
TR - Turchia 3
HK - Hong Kong 2
ID - Indonesia 2
CA - Canada 1
CH - Svizzera 1
ES - Italia 1
KR - Corea 1
LT - Lituania 1
PK - Pakistan 1
PL - Polonia 1
SI - Slovenia 1
TW - Taiwan 1
Totale 502
Città #
Parma 36
Chandler 33
Dublin 30
Milan 27
Ann Arbor 25
Singapore 22
Boardman 16
Ashburn 14
Shanghai 14
Amsterdam 13
Chicago 10
Abidjan 8
Modena 7
Auburn 6
Florence 6
Reggio Emilia 5
Bologna 4
Bottanuco 4
New York 4
Salsomaggiore Terme 4
Wayne 4
Alvignano 3
Helsinki 3
Istanbul 3
Leuven 3
Manchester 3
Marseille 3
Neviano degli Arduini 3
Rome 3
Rubiera 3
Verona 3
Bremen 2
Campi Bisenzio 2
Carpenedolo 2
Castellarano 2
Central 2
Chiari 2
Dallas 2
Des Moines 2
Fidenza 2
Fremont 2
Gioia Tauro 2
Hayamiya 2
Kolkata 2
Los Angeles 2
Maranello 2
Menteng 2
Pavia 2
Prata Di Pordenone 2
Princeton 2
Ravenna 2
Rottofreno 2
Sondrio 2
Vienna 2
Woodbridge 2
Brescia 1
Casalgrande 1
Castelverde 1
Cesano 1
Council Bluffs 1
Credaro 1
Desio 1
Fairfield 1
Ferrara 1
Gangseo-gu 1
Genoa 1
Grafing 1
Houston 1
Innsbruck 1
Kagoya 1
Karachi 1
Leawood 1
Ljubljana 1
London 1
Madrid 1
Munich 1
Naples 1
Osaka 1
Padova 1
Palermo 1
Paris 1
Piacenza 1
Pune 1
San Jose 1
Santa Clara 1
Sassuolo 1
Sesto San Giovanni 1
St. Moritz 1
Taipei 1
Taiyuan 1
Tokyo 1
Toronto 1
Torun 1
Yuncheng 1
Totale 409
Nome #
Efficacy of the cdk4/6 dual inhibitor abemaciclib in egfr-mutated nsclc cell lines with different resistance mechanisms to osimertinib 125
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells 75
PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC) 65
Isolation and characterization of H23 clones resistant to the KRASG12C inhibitors sotorasib and adagrasib 64
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models 64
Biological hallmarks and new therapeutic approaches for the treatment of pdac 58
PD-L1 OVEREXPRESSION INDUCES ANGIOGENIC CYTOKINE SECRETION AND ENDOTHELIAL CELL MIGRATION VIA STAT SIGNALLING. 56
Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators 13
Totale 520
Categoria #
all - tutte 2.096
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.096


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 0 6 6 9 0 5 7
2021/202245 7 4 12 0 2 1 3 0 5 0 2 9
2022/2023140 7 7 8 6 9 12 1 27 38 0 16 9
2023/2024186 3 9 12 5 19 22 16 17 7 7 36 33
2024/2025116 25 23 19 28 21 0 0 0 0 0 0 0
Totale 520